Alira Health

Alira Health

Alira Health Welcomes Richard Charter, Vice President, Market Access, MedTech, Europe & Asia-Pacific

News
Published on:
April 23, 2020

BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, welcomes Richard Charter as Vice President, Market Access, MedTech, Europe & Asia-Pacific to our office in Basel, Switzerland. Richard brings extensive experience in the MedTech industry and a comprehensive background in both financial and health economics to our Market Access Team.

At Alira Health, our aim is to become the number one market access MedTech player in the EU and U.S. by 2023. Richard’s vast experience and ability to create value for our customers and partners will help us to reach this goal and strengthen our commitment to a segment that is often overlooked for its size and complexity,” said Jean-François Ricci, Executive Vice President, Global Market Access, Alira Health. “Richard will lead Alira Health’s experienced MedTech Market Access Team in the EU, pioneer new MedTech specific methodologies and tools, and drive partnerships with the most important associations and academic institutions in the world to enable healthcare transformation for our MedTech clients.”

I am thrilled to join Alira Health’s senior leadership and join Jean-François and the Global Market Access Team in Basel, Switzerland,” said Richard. “This represents a fantastic opportunity to take Alira Health’s existing medical technology capabilities in product development, clinical trial development, and regulatory affairs, and further expand our MedTech market access capabilities. These capabilities are critical for successful product launch and payer/provider engagement. This team can deliver unparalleled solutions for our clients and lead MedTech Market Access globally.”

Richard brings over 15 years of experience in financial and health economics across multiple sectors, including financial services and healthcare. Richard has focused exclusively on the MedTech market access space, including leading the market access and pricing functions at a major medical device company.

Currently, Richard is the Co-chair of the ISPOR Medical Device Special Interest Group and Co-chair of the HTAi Medical Device Interest Group, the industry advisor to the EU-funded Horizon 2020 COMED initiative on cost and outcomes measurement for medical devices (COMED). Previously, Richard was the Chairperson of the MedTech Europe Evidence & Payers Working Group and core contributor to the Value-Based Procurement Working Group.

To learn more about our team

Click here

Related news

Reports May 20, 2024
Innovative Payment Schemes for Medtech in England, Germany, and France
This overview offers high-level details on the innovative payment schemes in England, Germany, and France.
MedTech
Case Studies May 14, 2024
Medtech Company Creates an Early Go-to-Market Strategy for Its Breakthrough IVD Solution
The client needed an early go-to-market strategy for their IVD solution to prepare for product development and launch in key European countries and the US.
IVDR Medical Devices MedTech
Case Studies May 8, 2024
Mid-Size Medtech Company with a Borderline Product Defines Strategy for EU Launch
Medtech company sought support in developing a regulatory strategy for the EU launch of their product with an aggressive timeline to launch.
Medical Devices MedTech Regulatory
Reports May 8, 2024
Value-Based Procurement in Australia
This white paper discusses why value-based healthcare and procurement are solutions in a robust healthcare system and identifies the medical technology sector as a collaborative partner(...)
MedTech Value-Based Contracts
Case Studies April 30, 2024
Medtech Company Leverages Bayesian Clinical Trial Design to Address FDA Feedback
A global medtech company needed help to address FDA feedback on their implant design that included a comparator and clearly demonstrated the safety and performance of this new device.
Clinical Trials Complex Innovative Design MedTech
Events April 30, 2024
The MedTech Forum 2024
We are thrilled to announce that we will exhibit and speak at The MedTech Forum 2024.
MedTech Regulatory
News April 29, 2024
Alira Health Advises Trill Impact Entering a Strategic Alliance with TT medic
We are pleased to have been a Commercial Due Diligence advisor for Trill Impact, a pioneering Impact House with around EUR 1.2 billion in assets under management, joining forces with(...)
CDD CDMO MedTech
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.